Zacks.com on MSN13h
RARE's Cholesterol Drug Evkeeza Gains EC Approval for Expanded UseUltragenyx Pharmaceutical RARE announced that the European Commission (EC) has expanded the eligible patient population for ...
The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce ...
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
The FDA has approved the first generic liraglutide indicated to improve glycemic control in adults and pediatric patients ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
On Dec. 20, the FDA announced that the agency has approved Eli Lilly's ... in adults with obesity. The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA ...
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to severe OSA in people with obesity.
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could be used for in adults and children 10 and up. The new drug ...
The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback